Kishimoto, T., Kojima, Y., & Fujimoto, N. (2021). Significance of secretory leukocyte peptidase inhibitor in pleural fluid for the diagnosis of benign asbestos pleural effusion. Sci Rep.
Citação norma ChicagoKishimoto, Takumi, Yoko Kojima, and Nobukazu Fujimoto. "Significance of Secretory Leukocyte Peptidase Inhibitor in Pleural Fluid for the Diagnosis of Benign Asbestos Pleural Effusion." Sci Rep 2021.
MLA citiranjeKishimoto, Takumi, Yoko Kojima, and Nobukazu Fujimoto. "Significance of Secretory Leukocyte Peptidase Inhibitor in Pleural Fluid for the Diagnosis of Benign Asbestos Pleural Effusion." Sci Rep 2021.
Opozorilo: Ti citati niso vedno 100% točni.